| Chelsea C Clark, RN, IBCLC | |
|
15 East Rd Unit 102, Fairfax, VT 05454-4450 | |
| (802) 363-3297 | |
| Not Available |
| Full Name | Chelsea C Clark |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Lactation Consultant |
| Location | 15 East Rd Unit 102, Fairfax, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578891040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WL0100X | Registered Nurse - Lactation Consultant | 026.0086622 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea C Clark, RN, IBCLC 15 East Rd Unit 102, Fairfax, VT 05454-4450 Ph: (802) 363-3297 | Chelsea C Clark, RN, IBCLC 15 East Rd Unit 102, Fairfax, VT 05454-4450 Ph: (802) 363-3297 |
News Archive
Journal of the National Cancer Institute: Projections Of The Cost Of Cancer Care In The United States: 2010-2020 - "By combining cancer prevalence with average annual costs of cancer care by phase of care and tumor site for 13 cancers in men and 16 cancers in women" and "all cancer sites combined," the authors project there will be just over 18 million cancer survivors in 2020 compared to 13.8 million survivors in 2010.
Robyn Wing, M.D., an emergency medicine physician at Hasbro Children's Hospital, recently led a study that found children who were exposed to an adverse childhood experience (ACE) were 28 percent more likely to develop asthma.
As the world watches the Vancouver Olympics, researchers at St. Michael's Hospital in Toronto and Children's Hospital Boston have teamed up to monitor and assess potential infectious disease threats to Vancouver during the Winter Games by integrating two independently developed intelligence systems that focus on global infectious diseases; bio.DIASPORA and HealthMap.
Response Genetics Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, and Genetic Technologies Ltd. (ASX: GTG; NASDAQ: GENE), the leading private genetic testing laboratory in Australia, today announced an exclusive distribution and services agreement.
Aceto Corporation, a global leader in the sourcing, quality assurance, regulatory support, marketing and distribution of pharmaceuticals, nutraceuticals, specialty chemicals and crop protection products, today announced that it has closed the previously announced transaction for its wholly-owned subsidiary to acquire certain assets of Rising Pharmaceuticals, Inc ("Rising").
› Verified 9 days ago